Efficacy of alternate mucosa-submucosa clip closure in preventing postoperative adverse events for patients with gastric mucosal lesions after endoscopic submucosal dissection: a multicenter retrospective study.
Lu Chen, Jingjing Jiang, Hongxia Li, Xin Yin, Xiajiao Tang, Yinnan Zhu, Wei Chen, Qin Lu, Ruihua Shi
{"title":"Efficacy of alternate mucosa-submucosa clip closure in preventing postoperative adverse events for patients with gastric mucosal lesions after endoscopic submucosal dissection: a multicenter retrospective study.","authors":"Lu Chen, Jingjing Jiang, Hongxia Li, Xin Yin, Xiajiao Tang, Yinnan Zhu, Wei Chen, Qin Lu, Ruihua Shi","doi":"10.1177/17562848251317145","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Endoscopic submucosal dissection (ESD) is the first-line treatment for gastric mucosal lesions. The artificial ulcers caused by ESD can lead to bleeding, perforation, and other adverse events.</p><p><strong>Objectives: </strong>This study aimed to evaluate the efficacy of alternate mucosa-submucosa clip in preventing adverse events following ESD for gastric mucosal lesions.</p><p><strong>Design: </strong>Multicenter retrospective observational study.</p><p><strong>Methods: </strong>Data from 924 patients who underwent ESD for gastric mucosal lesions were retrospectively collected and categorized into completely closed and unclosed groups based on postoperative wound management. The incidence of adverse events and postoperative wound healing rate at 1 and 3 months were compared between the groups, and the factors related to delayed bleeding after ESD were analyzed.</p><p><strong>Results: </strong>The rate of delayed hemorrhage was lower in the completely closed group than in the unclosed group (0.8% vs 7.6%; <i>p</i> < 0.001), and subgroup analysis showed that this effect was consistent across all subgroups. The postoperative abdominal pain score was lower in the completely closed group than in the unclosed group (0 vs 2, <i>p</i> < 0.001). One month postoperatively, the wound healing rate was higher in the completely closed group (77.6% vs 55.1%; <i>p</i> < 0.001). Multivariable analysis showed that the presence of ulcers or scars on the lesion surface, and lesions located in the lower one-third of the stomach were risk factors for postoperative bleeding.</p><p><strong>Conclusion: </strong>Application of alternate mucosa-submucosa clip closing the wound of ESD reduced the risk of postoperative bleeding, alleviated postoperative abdominal pain, and promoted artificial wound healing.</p>","PeriodicalId":48770,"journal":{"name":"Therapeutic Advances in Gastroenterology","volume":"18 ","pages":"17562848251317145"},"PeriodicalIF":3.9000,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792031/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562848251317145","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Endoscopic submucosal dissection (ESD) is the first-line treatment for gastric mucosal lesions. The artificial ulcers caused by ESD can lead to bleeding, perforation, and other adverse events.
Objectives: This study aimed to evaluate the efficacy of alternate mucosa-submucosa clip in preventing adverse events following ESD for gastric mucosal lesions.
Methods: Data from 924 patients who underwent ESD for gastric mucosal lesions were retrospectively collected and categorized into completely closed and unclosed groups based on postoperative wound management. The incidence of adverse events and postoperative wound healing rate at 1 and 3 months were compared between the groups, and the factors related to delayed bleeding after ESD were analyzed.
Results: The rate of delayed hemorrhage was lower in the completely closed group than in the unclosed group (0.8% vs 7.6%; p < 0.001), and subgroup analysis showed that this effect was consistent across all subgroups. The postoperative abdominal pain score was lower in the completely closed group than in the unclosed group (0 vs 2, p < 0.001). One month postoperatively, the wound healing rate was higher in the completely closed group (77.6% vs 55.1%; p < 0.001). Multivariable analysis showed that the presence of ulcers or scars on the lesion surface, and lesions located in the lower one-third of the stomach were risk factors for postoperative bleeding.
Conclusion: Application of alternate mucosa-submucosa clip closing the wound of ESD reduced the risk of postoperative bleeding, alleviated postoperative abdominal pain, and promoted artificial wound healing.
背景:内镜黏膜下剥离术(ESD)是胃黏膜病变的一线治疗方法。ESD引起的人工溃疡可导致出血、穿孔和其他不良事件:本研究旨在评估粘膜-粘膜下交替夹在预防ESD治疗胃粘膜病变后不良反应方面的疗效:多中心回顾性观察研究:回顾性收集924例接受ESD治疗胃黏膜病变患者的数据,并根据术后伤口处理情况分为完全闭合组和未闭合组。比较两组患者术后1个月和3个月的不良反应发生率和伤口愈合率,并分析ESD术后延迟出血的相关因素:结果:完全闭合组的延迟出血率低于未闭合组(0.8% vs 7.6%;P P P 结论:完全闭合组的延迟出血率低于未闭合组(0.8% vs 7.6%):应用粘膜-粘膜下交替夹闭合ESD伤口可降低术后出血风险,减轻术后腹痛,促进人工伤口愈合。
期刊介绍:
Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The editors welcome original research articles across all areas of gastroenterology and hepatology.
The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.